UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:CYP17A1-ANXA2 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: CYP17A1-ANXA2 | FusionPDB ID: 20998 | FusionGDB2.0 ID: 20998 | Hgene | Tgene | Gene symbol | CYP17A1 | ANXA2 | Gene ID | 1586 | 302 |
Gene name | cytochrome P450 family 17 subfamily A member 1 | annexin A2 | |
Synonyms | CPT7|CYP17|P450C17|S17AH | ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV | |
Cytomap | 10q24.32 | 15q22.2 | |
Type of gene | protein-coding | protein-coding | |
Description | steroid 17-alpha-hydroxylase/17,20 lyase17-alpha-hydroxyprogesterone aldolaseCYPXVIIcytochrome P450 17A1cytochrome P450, family 17, subfamily A, polypeptide 1cytochrome P450, subfamily XVII (steroid 17-alpha-hydroxylase), adrenal hyperplasiacytochro | annexin A2annexin IIannexin-2calpactin I heavy chaincalpactin I heavy polypeptidecalpactin-1 heavy chainchromobindin 8epididymis secretory protein Li 270epididymis secretory sperm binding proteinlipocortin IIplacental anticoagulant protein IVpr | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P05093 | A6NMY6 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000369887, ENST00000489268, | ENST00000557937, ENST00000332680, ENST00000396024, ENST00000421017, ENST00000451270, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 7 X 6 X 3=126 | 33 X 12 X 13=5148 |
# samples | 7 | 39 | |
** MAII score | log2(7/126*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(39/5148*10)=-3.72246602447109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: CYP17A1 [Title/Abstract] AND ANXA2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CYP17A1(104591265)-ANXA2(60643450), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CYP17A1-ANXA2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CYP17A1-ANXA2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CYP17A1 | GO:0008202 | steroid metabolic process | 22266943 |
Hgene | CYP17A1 | GO:0042446 | hormone biosynthetic process | 22266943 |
Hgene | CYP17A1 | GO:0042448 | progesterone metabolic process | 22266943 |
Tgene | ANXA2 | GO:0001921 | positive regulation of receptor recycling | 22848640 |
Tgene | ANXA2 | GO:0031340 | positive regulation of vesicle fusion | 2138016 |
Tgene | ANXA2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 22848640 |
Tgene | ANXA2 | GO:0036035 | osteoclast development | 7961821 |
Tgene | ANXA2 | GO:1905581 | positive regulation of low-density lipoprotein particle clearance | 22848640 |
Tgene | ANXA2 | GO:1905597 | positive regulation of low-density lipoprotein particle receptor binding | 22848640 |
Tgene | ANXA2 | GO:1905602 | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 22848640 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ACC | TCGA-OR-A5J7-01A | CYP17A1 | chr10 | 104591265 | - | ANXA2 | chr15 | 60643450 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000369887 | CYP17A1 | chr10 | 104591265 | - | ENST00000396024 | ANXA2 | chr15 | 60643450 | - | 2153 | 1415 | 115 | 1656 | 513 |
ENST00000369887 | CYP17A1 | chr10 | 104591265 | - | ENST00000451270 | ANXA2 | chr15 | 60643450 | - | 1960 | 1415 | 115 | 1656 | 513 |
ENST00000369887 | CYP17A1 | chr10 | 104591265 | - | ENST00000332680 | ANXA2 | chr15 | 60643450 | - | 1955 | 1415 | 115 | 1656 | 513 |
ENST00000369887 | CYP17A1 | chr10 | 104591265 | - | ENST00000421017 | ANXA2 | chr15 | 60643450 | - | 1945 | 1415 | 115 | 1656 | 513 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000369887 | ENST00000396024 | CYP17A1 | chr10 | 104591265 | - | ANXA2 | chr15 | 60643450 | - | 0.001971106 | 0.99802893 |
ENST00000369887 | ENST00000451270 | CYP17A1 | chr10 | 104591265 | - | ANXA2 | chr15 | 60643450 | - | 0.002966134 | 0.99703383 |
ENST00000369887 | ENST00000332680 | CYP17A1 | chr10 | 104591265 | - | ANXA2 | chr15 | 60643450 | - | 0.003044676 | 0.9969553 |
ENST00000369887 | ENST00000421017 | CYP17A1 | chr10 | 104591265 | - | ANXA2 | chr15 | 60643450 | - | 0.003231672 | 0.99676836 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >20998_20998_1_CYP17A1-ANXA2_CYP17A1_chr10_104591265_ENST00000369887_ANXA2_chr15_60643450_ENST00000332680_length(amino acids)=513AA_BP=433 MPQLFYSTAVYLACRHPATMWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTK TTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHN GQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYK EKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRT PTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPVQCIQNKPLYFADRLYD -------------------------------------------------------------- >20998_20998_2_CYP17A1-ANXA2_CYP17A1_chr10_104591265_ENST00000369887_ANXA2_chr15_60643450_ENST00000396024_length(amino acids)=513AA_BP=433 MPQLFYSTAVYLACRHPATMWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTK TTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHN GQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYK EKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRT PTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPVQCIQNKPLYFADRLYD -------------------------------------------------------------- >20998_20998_3_CYP17A1-ANXA2_CYP17A1_chr10_104591265_ENST00000369887_ANXA2_chr15_60643450_ENST00000421017_length(amino acids)=513AA_BP=433 MPQLFYSTAVYLACRHPATMWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTK TTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHN GQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYK EKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRT PTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPVQCIQNKPLYFADRLYD -------------------------------------------------------------- >20998_20998_4_CYP17A1-ANXA2_CYP17A1_chr10_104591265_ENST00000369887_ANXA2_chr15_60643450_ENST00000451270_length(amino acids)=513AA_BP=433 MPQLFYSTAVYLACRHPATMWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTK TTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHN GQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYK EKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRT PTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPVQCIQNKPLYFADRLYD -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:104591265/chr15:60643450) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CYP17A1 | ANXA2 |
FUNCTION: A cytochrome P450 monooxygenase involved in corticoid and androgen biosynthesis (PubMed:9452426, PubMed:27339894, PubMed:22266943, PubMed:25301938). Catalyzes 17-alpha hydroxylation of C21 steroids, which is common for both pathways. A second oxidative step, required only for androgen synthesis, involves an acyl-carbon cleavage. The 17-alpha hydroxy intermediates, as part of adrenal glucocorticoids biosynthesis pathway, are precursors of cortisol (PubMed:9452426, PubMed:25301938) (Probable). Hydroxylates steroid hormones, pregnenolone and progesterone to form 17-alpha hydroxy metabolites, followed by the cleavage of the C17-C20 bond to form C19 steroids, dehydroepiandrosterone (DHEA) and androstenedione (PubMed:9452426, PubMed:27339894, PubMed:22266943, PubMed:25301938). Has 16-alpha hydroxylase activity. Catalyzes 16-alpha hydroxylation of 17-alpha hydroxy pregnenolone, followed by the cleavage of the C17-C20 bond to form 16-alpha-hydroxy DHEA. Also 16-alpha hydroxylates androgens, relevant for estriol synthesis (PubMed:27339894, PubMed:25301938). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:9452426, PubMed:27339894, PubMed:22266943, PubMed:25301938). {ECO:0000269|PubMed:22266943, ECO:0000269|PubMed:25301938, ECO:0000269|PubMed:27339894, ECO:0000269|PubMed:9452426, ECO:0000305|PubMed:8027220}. | FUNCTION: Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. {ECO:0000250}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000396024 | 10 | 14 | 265_336 | 259.3333333333333 | 340.0 | Repeat | Annexin 4 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000421017 | 10 | 14 | 265_336 | 259.3333333333333 | 340.0 | Repeat | Annexin 4 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000451270 | 9 | 13 | 265_336 | 259.3333333333333 | 340.0 | Repeat | Annexin 4 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000332680 | 9 | 13 | 2_24 | 277.3333333333333 | 358.0 | Region | S100A10-binding site | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000396024 | 10 | 14 | 2_24 | 259.3333333333333 | 340.0 | Region | S100A10-binding site | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000421017 | 10 | 14 | 2_24 | 259.3333333333333 | 340.0 | Region | S100A10-binding site | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000451270 | 9 | 13 | 2_24 | 259.3333333333333 | 340.0 | Region | S100A10-binding site | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000332680 | 9 | 13 | 105_176 | 277.3333333333333 | 358.0 | Repeat | Annexin 2 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000332680 | 9 | 13 | 189_261 | 277.3333333333333 | 358.0 | Repeat | Annexin 3 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000332680 | 9 | 13 | 265_336 | 277.3333333333333 | 358.0 | Repeat | Annexin 4 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000332680 | 9 | 13 | 33_104 | 277.3333333333333 | 358.0 | Repeat | Annexin 1 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000396024 | 10 | 14 | 105_176 | 259.3333333333333 | 340.0 | Repeat | Annexin 2 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000396024 | 10 | 14 | 189_261 | 259.3333333333333 | 340.0 | Repeat | Annexin 3 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000396024 | 10 | 14 | 33_104 | 259.3333333333333 | 340.0 | Repeat | Annexin 1 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000421017 | 10 | 14 | 105_176 | 259.3333333333333 | 340.0 | Repeat | Annexin 2 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000421017 | 10 | 14 | 189_261 | 259.3333333333333 | 340.0 | Repeat | Annexin 3 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000421017 | 10 | 14 | 33_104 | 259.3333333333333 | 340.0 | Repeat | Annexin 1 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000451270 | 9 | 13 | 105_176 | 259.3333333333333 | 340.0 | Repeat | Annexin 2 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000451270 | 9 | 13 | 189_261 | 259.3333333333333 | 340.0 | Repeat | Annexin 3 | |
Tgene | ANXA2 | chr10:104591265 | chr15:60643450 | ENST00000451270 | 9 | 13 | 33_104 | 259.3333333333333 | 340.0 | Repeat | Annexin 1 |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
CYP17A1 | |
ANXA2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to CYP17A1-ANXA2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to CYP17A1-ANXA2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |